BackPURE Bioscience Overview

PURE Bioscience EBIT

EBIT (Earnings Before Interest and Taxes) analysis for PURE.

Quarterly EBIT

-$518.00K
3.19% YoY

As of Apr 30, 2026

Annual EBIT (TTM)

-$1.81M
29.21% YoY

Trailing 12 months ending Apr 30, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)